The Effect of Nanofat Injection on Androgenetic Alopecia

Starting soon · Phase 4

Conditions studied: Androgenetic Alopecia, Androgenetic Alopecia (AGA)

In brief

Androgenetic alopecia is a condition that bothers a lot of people. The disadvantage of the FDA approved topical minoxidil is that the patient needs to be compliant every day for extended periods of time. This is the main reason why this study is being conducted, to see if a single nanofat injection is superior to applying either topical Minoxidil or PRP

Key facts

Study ID

NCT07518342

Run by

Assiut University

People needed

60

Starts

2026-04-01

Expected to finish

2028-12-01

Last updated by the study team

2026-04-13

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (ages 18-50).
• A clinical diagnosis of androgenetic alopecia confirmed by dermoscopy of both males and females.
• No previous topical treatment used in the past 3 months.

You may not qualify if…

• Alopecia totalis and alopecia universalis.
• Cicatricial alopecia.
• Other causes of hair loss such as immunological disease.
• Skin disease in the affected area.
• Hypersensitivity or allergy to any of the treatment products used.
• Patients using treatment (topical or systemic) for androgenetic alopecia in the last 3 months.
• Pregnant and lactating females.
• Patients with a history of hypertrophic scars or keloid formation.
• Patients with active infection at the site of the lesion.
• Skin disease in the affected area.
• Hamilton norwood scale stage 6 and 7
• Ludwig Scale stage 3

Where it is running

• Assiut University — Asyut, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.